DermView raises €1.9m to fund expansion after winning NHS contract

DermView, an Irish company behind a chain of dermatology clinics, has raised €1.9 million in seed funding at a €8.2 million valuation.

The oversubscribed funding round attracted high-profile investors, including property developer Michael Cotter, Donagh Barry of the Barry’s Tea family, Irrus Investments, and Tim Crowley, leading a private group from Park Developments.

The company plans to use the funding to expand its skin imaging services in Britain, where it recently won an NHS contract. DermView offers high-tech skin imaging that enables quicker diagnosis and treatment plans for patients, and it aims to expand into ophthalmology.

The company is pursuing significant expansion plans, including opening two new 4,000 sq ft facilities on either side of Dublin, expanding into Northern Ireland, and partnering with the NHS to open facilities across Britain in the new year.

As a chosen partner of the NHS consortium, DermView is working to enable skin artificial intelligence throughout the UK by 2025.

DermView’s board includes former AIB and Central Bank director Bernard Somers and ex-Health Service Executive director general Tony O’Brien.